Literature DB >> 2561993

Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: an in situ hybridization study.

B J Morris1, A Herz, V Höllt.   

Abstract

In situ hybridization was used to study the macroscopic distribution and regulatory control of proenkephalin mRNA and prodynorphin mRNA in rat striatum. While proenkephalin mRNA was widely distributed throughout the striatum, levels of prodynorphin mRNA were highest in the medial and ventral portions of the striatum. Furthermore, in contrast to the results for proenkephalin mRNA, the levels of prodynorphin mRNA appeared higher in the nucleus accumbens than in the striatum. The mesostriatal dopaminergic pathway was destroyed by discrete, unilateral injection of 6-hydroxy-dopamine (6-OHDA) into either the substantia nigra or the neighboring ventral tegmental area (VTA). Lesions of the substantia nigra caused a dramatic ipsilateral increase in the hybridization signal for proenkephalin mRNA, but no change was observed in the hybridization signal for prodynorphin mRNA. Similar effects were seen with VTA lesions. Since destruction of the mesostriatal dopamine system elevates the levels of proenkephalin mRNA, but not of prodynorphin mRNA, in the striatal target neurons, it appears that the mesostriatal pathway exerts a tonic and selective suppression of striatal proenkephalin gene expression at the mRNA level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2561993     DOI: 10.1007/BF02896851

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  44 in total

1.  Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA.

Authors:  J A Angulo; L G Davis; B A Burkhart; G R Christoph
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

2.  Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization.

Authors:  R E Harlan; B D Shivers; G J Romano; R D Howells; D W Pfaff
Journal:  J Comp Neurol       Date:  1987-04-08       Impact factor: 3.215

3.  Enkephalin biosynthesis and enkephalin gene expression are increased in hippocampal mossy fibers following a unilateral lesion of the hilus.

Authors:  J D White; C M Gall; J F McKelvy
Journal:  J Neurosci       Date:  1987-03       Impact factor: 6.167

4.  Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum.

Authors:  M Herkenham; C B Pert
Journal:  Nature       Date:  1981-06-04       Impact factor: 49.962

5.  Enkephalin biosynthesis in adrenal medulla. Modulation of proenkephalin mRNA content of cultured chromaffin cells by 8-bromo-adenosine 3',5'-monophosphate.

Authors:  T T Quach; F Tang; H Kageyama; I Mocchetti; A Guidotti; J L Meek; E Costa; J P Schwartz
Journal:  Mol Pharmacol       Date:  1984-09       Impact factor: 4.436

6.  Sequence and expression of the rat prodynorphin gene.

Authors:  O Civelli; J Douglass; A Goldstein; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  In situ hybridization histochemistry for the analysis of gene expression in the endocrine and central nervous system tissues: a 3-year experience.

Authors:  B Bloch; T Popovici; D Le Guellec; E Normand; S Chouham; A F Guitteny; P Bohlen
Journal:  J Neurosci Res       Date:  1986       Impact factor: 4.164

8.  Kainic acid alters the metabolism of Met5-enkephalin and the level of dynorphin A in the rat hippocampus.

Authors:  T Kanamatsu; J Obie; L Grimes; J F McGinty; K Yoshikawa; S Sabol; J S Hong
Journal:  J Neurosci       Date:  1986-10       Impact factor: 6.167

9.  Tyrosine 3-hydroxylase in rat brain and adrenal medulla: hybridization histochemistry and immunohistochemistry combined with retrograde tracing.

Authors:  M Schalling; T Hökfelt; B Wallace; M Goldstein; D Filer; C Yamin; D H Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

10.  Quantitation of proenkephalin A messenger RNA in bovine brain, pituitary and adrenal medulla: correlation between mRNA and peptide levels.

Authors:  C W Pittius; N Kley; J P Loeffler; V Höllt
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  6 in total

1.  Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.

Authors:  Yunmin Ding; Jacqueline Restrepo; Lisa Won; Dong-Youn Hwang; Kwang-Soo Kim; Un Jung Kang
Journal:  Neurobiol Dis       Date:  2007-04-10       Impact factor: 5.996

Review 2.  Factors regulating the activity of striatal neurons: new perspectives from in situ hybridization histochemistry.

Authors:  B Morris
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

3.  Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin and alpha 3 nicotinic receptor subunit in the rat.

Authors:  V Höllt; G Horn
Journal:  Clin Investig       Date:  1992 Mar-Apr

4.  Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.

Authors:  G D Phillips; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

5.  Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.

Authors:  R Granata; G K Wenning; J Jolkkonen; P Jenner; C D Marsden
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.

Authors:  Jean Lud Cadet; Christie Brannock; Irina N Krasnova; Bruce Ladenheim; Michael T McCoy; Jenny Chou; Elin Lehrmann; William H Wood; Kevin G Becker; Yun Wang
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.